相关实验视频

Updated: May 4, 2026

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

使用F-Pentixa用于PET/CT和机器学习,在初级阿尔多色素学中对CYP11B2定义的亚型进行非侵入性预测

Yuqi Zhao¹, Ying Chen², Furui Duan¹

¹PET/CT Department, The Second Affiliated Hospital of Harbin Medical University, No. 246, Xuefu Road, Nangang District, Harbin, Heilongjiang Province, China.

Academic radiology

|January 13, 2026

概括

一个可解释的机器学习模型使用PET/CT成像准确地预测了原发性阿尔多斯特隆症 (PA) 亚型. 这种非侵入性方法有助于个性化治疗决策,可能减少侵入性上腺静脉采样的需要.

科学领域:

核医学成像技术核医学成像技术
机器学习在医疗保健中的应用
内分泌学和代谢性疾病.

背景情况:

原发性阿尔多斯特隆症 (PA) 是二次高血压的常见原因之一.
精确地分类PA对于指导治疗决策至关重要.
当前的诊断方法可能是侵入性的,可能并不总是确定的.

研究的目的:

开发和验证可解释的机器学习模型,用于非侵入性预测PA病理亚型.
为了整合临床数据,放射学和深度学习 (DL) 功能从18F-AlF-NOTA-Pentixafor PET/CT.
为了提高诊断准确度,并促进个人化管理PA.

主要方法:

对89名接受PET/CT治疗的PA患者进行了回顾性分析.
使用支持矢量机 (SVM) 算法开发预测模型.
临床,放射学和DL特征的整合与两阶段特征选择.
模型性能使用AUC,校准和决策曲线分析进行评估;可通过SHAP解释性.

主要成果:

组合模型在测试组中实现了卓越的诊断准确性 (AUC 0.907,灵敏度为1.000,F1得分为0.923).
综合模型的表现明显优于单个临床,放射学和DL模型 (p<0.01).
SHAP分析突出了关键的放射学和DL特征,与CXCR4和CYP11B2表达等生物标志物保持一致.

结论:

一个可解释的机器学习模型可以准确地预测经过手术确认的PA亚型.
这种人工智能驱动的方法可能会减少对侵入性上腺静脉采样的依赖.
该模型支持PA患者个性化手术决策.

关键词:

(18)F-AlF-NOTA-pentixafor的使用情况在CYP11B2中.主要的阿尔多斯特主义.这就是 SHAP SHAP 的意思.在SVM中,SVM是SVM.

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...